- id: 11
  properties:
    _type: ScheduleTimelineExit
    id: ScheduleTimelineExit_1
    label: ScheduleTimelineExit_1
- id: 13
  properties:
    _type: Timing
    description: null
    id: Timing_1
    label: Timing_1
    name: TIMING_3
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_84
    timingValue: PT0M
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x2
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Before
      id: Code_82
- id: 12
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_1
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_1
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 17
  properties:
    _type: Timing
    description: 24 Hours
    id: Timing_2
    label: Timing_2
    name: TIMING_4
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_89
    timingValue: PT24H
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x2
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Before
      id: Code_87
- id: 16
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_2
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_2
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 21
  properties:
    _type: Timing
    description: null
    id: Timing_3
    label: Timing_3
    name: TIMING_5
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_94
    timingValue: PT0M
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x3
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Fixed Reference
      id: Code_90
- id: 20
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_3
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_3
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 25
  properties:
    _type: Timing
    description: +13 Days
    id: Timing_4
    label: Timing_4
    name: TIMING_6
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_99
    timingValue: P13D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_96
- id: 24
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_4
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_4
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 29
  properties:
    _type: Timing
    description: +1 Days
    id: Timing_5
    label: Timing_5
    name: TIMING_7
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_104
    timingValue: P1D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_101
- id: 28
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_5
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_5
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 33
  properties:
    _type: Timing
    description: +14 Days
    id: Timing_6
    label: Timing_6
    name: TIMING_8
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_109
    timingValue: P14D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_106
- id: 32
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_6
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_6
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 37
  properties:
    _type: Timing
    description: +1 Days
    id: Timing_7
    label: Timing_7
    name: TIMING_9
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_114
    timingValue: P1D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_111
- id: 36
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_7
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_7
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 41
  properties:
    _type: Timing
    description: +13 Days
    id: Timing_8
    label: Timing_8
    name: TIMING_10
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_119
    timingValue: P13D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_116
- id: 40
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_8
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_8
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 45
  properties:
    _type: Timing
    description: +14 Days
    id: Timing_9
    label: Timing_9
    name: TIMING_11
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_124
    timingValue: P14D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_121
- id: 44
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_9
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_9
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 49
  properties:
    _type: Timing
    description: +1 Days
    id: Timing_10
    label: Timing_10
    name: TIMING_12
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_129
    timingValue: P1D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_126
- id: 48
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_10
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_10
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 53
  properties:
    _type: Timing
    description: +27 Days
    id: Timing_11
    label: Timing_11
    name: TIMING_13
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_134
    timingValue: P27D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_131
- id: 52
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_11
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_11
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 57
  properties:
    _type: Timing
    description: +1 Days
    id: Timing_12
    label: Timing_12
    name: TIMING_14
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_139
    timingValue: P1D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_136
- id: 56
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_12
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_12
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 61
  properties:
    _type: Timing
    description: +27 Days
    id: Timing_13
    label: Timing_13
    name: TIMING_15
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_144
    timingValue: P27D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_141
- id: 60
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_13
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_13
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 65
  properties:
    _type: Timing
    description: +1 Days
    id: Timing_14
    label: Timing_14
    name: TIMING_16
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_149
    timingValue: P1D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_146
- id: 64
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_14
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_14
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 69
  properties:
    _type: Timing
    description: +27 Days
    id: Timing_15
    label: Timing_15
    name: TIMING_17
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_154
    timingValue: P27D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_151
- id: 68
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_15
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_15
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 73
  properties:
    _type: Timing
    description: +1 Days
    id: Timing_16
    label: Timing_16
    name: TIMING_18
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_159
    timingValue: P1D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_156
- id: 72
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_16
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_16
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 77
  properties:
    _type: Timing
    description: +27 Days
    id: Timing_17
    label: Timing_17
    name: TIMING_19
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_164
    timingValue: P27D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_161
- id: 76
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_17
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_17
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 81
  properties:
    _type: Timing
    description: +14 Days
    id: Timing_18
    label: Timing_18
    name: TIMING_20
    timingRelativeToFrom:
      _type: Code
      code: C99900x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Start to Start
      id: Code_169
    timingValue: P14D
    timingWindow: null
    timingWindowLower: null
    timingWindowUpper: null
    type:
      _type: Code
      code: C99901x1
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: After
      id: Code_166
- id: 80
  properties:
    _type: ScheduledActivityInstance
    id: ScheduledActivityInstance_18
    instanceType: ACTIVITY
    label: ScheduledActivityInstance_18
    scheduleTimelineExitId: null
    scheduledInstanceTimelineId: null
- id: 10
  properties:
    _type: ScheduleTimeline
    description: This is the main timeline for the study design.
    entryCondition: Potential subject identified
    id: ScheduleTimeline_1
    label: ScheduleTimeline_1
    mainTimeline: true
    name: Main Timeline
    scheduleTimelineEntryId: ScheduledActivityInstance_1
- id: 86
  properties:
    _type: Encounter
    description: Screening encounter
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_9
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_8
    encounterScheduledAtTimingId: null
    id: Encounter_1
    label: Encounter_1
    name: Screening 1
    nextEncounterId: Encounter_2
    previousEncounterId: null
    transitionEndRule: {}
    transitionStartRule: {}
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_7
- id: 90
  properties:
    _type: Encounter
    description: Screening encounter - Ambulatory ECG Placement
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_12
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_11
    encounterScheduledAtTimingId: null
    id: Encounter_2
    label: Encounter_2
    name: Screening 2
    nextEncounterId: Encounter_3
    previousEncounterId: Encounter_1
    transitionEndRule: {}
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_10
- id: 94
  properties:
    _type: Encounter
    description: Baseline encounter - Ambulatory ECG Removal
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_15
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_14
    encounterScheduledAtTimingId: null
    id: Encounter_3
    label: Encounter_3
    name: Baseline
    nextEncounterId: Encounter_4
    previousEncounterId: Encounter_2
    transitionEndRule: {}
    transitionStartRule: {}
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_13
- id: 98
  properties:
    _type: Encounter
    description: Day 13 - Ambulatory ECG Placement
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_18
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_17
    encounterScheduledAtTimingId: null
    id: Encounter_4
    label: Encounter_4
    name: Week 1
    nextEncounterId: Encounter_5
    previousEncounterId: Encounter_3
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_16
- id: 102
  properties:
    _type: Encounter
    description: Day 14
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_21
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_20
    encounterScheduledAtTimingId: null
    id: Encounter_5
    label: Encounter_5
    name: Week 2
    nextEncounterId: Encounter_6
    previousEncounterId: Encounter_4
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_19
- id: 106
  properties:
    _type: Encounter
    description: Day 28
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_24
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_23
    encounterScheduledAtTimingId: null
    id: Encounter_6
    label: Encounter_6
    name: Week 4
    nextEncounterId: Encounter_7
    previousEncounterId: Encounter_5
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_22
- id: 110
  properties:
    _type: Encounter
    description: "Day 30 - Ambulatory ECG \_Removal"
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_27
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_26
    encounterScheduledAtTimingId: null
    id: Encounter_7
    label: Encounter_7
    name: Week 5
    nextEncounterId: Encounter_8
    previousEncounterId: Encounter_6
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_25
- id: 114
  properties:
    _type: Encounter
    description: Day 42
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_30
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_29
    encounterScheduledAtTimingId: null
    id: Encounter_8
    label: Encounter_8
    name: Week 6
    nextEncounterId: Encounter_9
    previousEncounterId: Encounter_7
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_28
- id: 118
  properties:
    _type: Encounter
    description: Day 56
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_33
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_32
    encounterScheduledAtTimingId: null
    id: Encounter_9
    label: Encounter_9
    name: Week 8
    nextEncounterId: Encounter_10
    previousEncounterId: Encounter_8
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_31
- id: 122
  properties:
    _type: Encounter
    description: Day 70
    encounterContactModes:
    - _type: Code
      code: C171537
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Telephone Call
      id: Code_36
    encounterEnvironmentalSetting:
      _type: Code
      code: C18002
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Home
      id: Code_35
    encounterScheduledAtTimingId: null
    id: Encounter_10
    label: Encounter_10
    name: "Week\_10\_(T)"
    nextEncounterId: Encounter_11
    previousEncounterId: Encounter_9
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_34
- id: 126
  properties:
    _type: Encounter
    description: Day 84
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_39
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_38
    encounterScheduledAtTimingId: null
    id: Encounter_11
    label: Encounter_11
    name: Week 12
    nextEncounterId: Encounter_12
    previousEncounterId: Encounter_10
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_37
- id: 130
  properties:
    _type: Encounter
    description: Day 98
    encounterContactModes:
    - _type: Code
      code: C171537
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Telephone Call
      id: Code_42
    encounterEnvironmentalSetting:
      _type: Code
      code: C18002
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Home
      id: Code_41
    encounterScheduledAtTimingId: null
    id: Encounter_12
    label: Encounter_12
    name: Week 14 (T)
    nextEncounterId: Encounter_13
    previousEncounterId: Encounter_11
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_40
- id: 134
  properties:
    _type: Encounter
    description: Day 112
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_45
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_44
    encounterScheduledAtTimingId: null
    id: Encounter_13
    label: Encounter_13
    name: Week 16
    nextEncounterId: Encounter_14
    previousEncounterId: Encounter_12
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_43
- id: 138
  properties:
    _type: Encounter
    description: Day 126
    encounterContactModes:
    - _type: Code
      code: C171537
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Telephone Call
      id: Code_48
    encounterEnvironmentalSetting:
      _type: Code
      code: C18002
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Home
      id: Code_47
    encounterScheduledAtTimingId: null
    id: Encounter_14
    label: Encounter_14
    name: Week 18 (T)
    nextEncounterId: Encounter_15
    previousEncounterId: Encounter_13
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_46
- id: 142
  properties:
    _type: Encounter
    description: Day 140
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_51
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_50
    encounterScheduledAtTimingId: null
    id: Encounter_15
    label: Encounter_15
    name: Week 20
    nextEncounterId: Encounter_16
    previousEncounterId: Encounter_14
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_49
- id: 146
  properties:
    _type: Encounter
    description: Day 154
    encounterContactModes:
    - _type: Code
      code: C171537
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Telephone Call
      id: Code_54
    encounterEnvironmentalSetting:
      _type: Code
      code: C18002
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Home
      id: Code_53
    encounterScheduledAtTimingId: null
    id: Encounter_16
    label: Encounter_16
    name: Week 22 (T)
    nextEncounterId: Encounter_17
    previousEncounterId: Encounter_15
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_52
- id: 150
  properties:
    _type: Encounter
    description: Day 168
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_57
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_56
    encounterScheduledAtTimingId: null
    id: Encounter_17
    label: Encounter_17
    name: Week 24
    nextEncounterId: Encounter_18
    previousEncounterId: Encounter_16
    transitionEndRule: null
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_55
- id: 154
  properties:
    _type: Encounter
    description: Day 182
    encounterContactModes:
    - _type: Code
      code: C175574
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: In Person
      id: Code_60
    encounterEnvironmentalSetting:
      _type: Code
      code: C51282
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Clinic
      id: Code_59
    encounterScheduledAtTimingId: null
    id: Encounter_18
    label: Encounter_18
    name: Week 26
    nextEncounterId: null
    previousEncounterId: Encounter_17
    transitionEndRule: {}
    transitionStartRule: null
    type:
      _type: Code
      code: C25716
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Visit
      id: Code_58
- id: 158
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Informed consent
    id: Activity_1
    label: Activity_1
    name: Informed consent
    nextActivityId: Activity_2
    previousActivityId: null
- id: 159
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Inclusion/exclusion criteria
    id: Activity_2
    label: Activity_2
    name: Inclusion/exclusion criteria
    nextActivityId: Activity_3
    previousActivityId: Activity_1
- id: 160
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Patient number assigned
    id: Activity_3
    label: Activity_3
    name: Patient number assigned
    nextActivityId: Activity_4
    previousActivityId: Activity_2
- id: 161
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Demographics
    id: Activity_4
    label: Activity_4
    name: Demographics
    nextActivityId: Activity_5
    previousActivityId: Activity_3
- id: 162
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Hachinski <= 4
    id: Activity_5
    label: Activity_5
    name: Hachinski <= 4
    nextActivityId: Activity_6
    previousActivityId: Activity_4
- id: 163
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: MMSE 10-23
    id: Activity_6
    label: Activity_6
    name: MMSE 10-23
    nextActivityId: Activity_7
    previousActivityId: Activity_5
- id: 164
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Physical examination
    id: Activity_7
    label: Activity_7
    name: Physical examination
    nextActivityId: Activity_8
    previousActivityId: Activity_6
- id: 165
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Medical history
    id: Activity_8
    label: Activity_8
    name: Medical history
    nextActivityId: Activity_9
    previousActivityId: Activity_7
- id: 166
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Habits
    id: Activity_9
    label: Activity_9
    name: Habits
    nextActivityId: Activity_10
    previousActivityId: Activity_8
- id: 167
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Chest X-ray
    id: Activity_10
    label: Activity_10
    name: Chest X-ray
    nextActivityId: Activity_11
    previousActivityId: Activity_9
- id: 168
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Apo E genotyping
    id: Activity_11
    label: Activity_11
    name: Apo E genotyping
    nextActivityId: Activity_12
    previousActivityId: Activity_10
- id: 169
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Patient randomised
    id: Activity_12
    label: Activity_12
    name: Patient randomised
    nextActivityId: Activity_13
    previousActivityId: Activity_11
- id: 170
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Vital signs /Temperature
    id: Activity_13
    label: Activity_13
    name: Vital signs /Temperature
    nextActivityId: Activity_14
    previousActivityId: Activity_12
- id: 171
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Ambulatory ECG placed
    id: Activity_14
    label: Activity_14
    name: Ambulatory ECG placed
    nextActivityId: Activity_15
    previousActivityId: Activity_13
- id: 172
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Ambulatory ECG removed
    id: Activity_15
    label: Activity_15
    name: Ambulatory ECG removed
    nextActivityId: Activity_16
    previousActivityId: Activity_14
- id: 173
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: ECG
    id: Activity_16
    label: Activity_16
    name: ECG
    nextActivityId: Activity_17
    previousActivityId: Activity_15
- id: 174
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Placebo TTS test
    id: Activity_17
    label: Activity_17
    name: Placebo TTS test
    nextActivityId: Activity_18
    previousActivityId: Activity_16
- id: 175
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: CT scan
    id: Activity_18
    label: Activity_18
    name: CT scan
    nextActivityId: Activity_19
    previousActivityId: Activity_17
- id: 176
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Concomitant medications
    id: Activity_19
    label: Activity_19
    name: Concomitant medications
    nextActivityId: Activity_20
    previousActivityId: Activity_18
- id: 177
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Hematology
    id: Activity_20
    label: Activity_20
    name: Hematology
    nextActivityId: Activity_21
    previousActivityId: Activity_19
- id: 178
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Chemistry
    id: Activity_21
    label: Activity_21
    name: Chemistry
    nextActivityId: Activity_22
    previousActivityId: Activity_20
- id: 179
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Uninalysis
    id: Activity_22
    label: Activity_22
    name: Uninalysis
    nextActivityId: Activity_23
    previousActivityId: Activity_21
- id: 180
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: 'Plasma Specimen

      (Xanomeline)'
    id: Activity_23
    label: Activity_23
    name: 'Plasma Specimen

      (Xanomeline)'
    nextActivityId: Activity_24
    previousActivityId: Activity_22
- id: 181
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Hemoglobin A1C
    id: Activity_24
    label: Activity_24
    name: Hemoglobin A1C
    nextActivityId: Activity_25
    previousActivityId: Activity_23
- id: 182
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: 'Study drug record

      Medications dispensed

      Medications returned'
    id: Activity_25
    label: Activity_25
    name: 'Study drug record

      Medications dispensed

      Medications returned'
    nextActivityId: Activity_26
    previousActivityId: Activity_24
- id: 183
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: TTS Acceptability Survey
    id: Activity_26
    label: Activity_26
    name: TTS Acceptability Survey
    nextActivityId: Activity_27
    previousActivityId: Activity_25
- id: 184
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: ADAS-Cog
    id: Activity_27
    label: Activity_27
    name: ADAS-Cog
    nextActivityId: Activity_28
    previousActivityId: Activity_26
- id: 185
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: CIBIC+
    id: Activity_28
    label: Activity_28
    name: CIBIC+
    nextActivityId: Activity_29
    previousActivityId: Activity_27
- id: 186
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: DAD
    id: Activity_29
    label: Activity_29
    name: DAD
    nextActivityId: Activity_30
    previousActivityId: Activity_28
- id: 187
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: NPI-X
    id: Activity_30
    label: Activity_30
    name: NPI-X
    nextActivityId: Activity_31
    previousActivityId: Activity_29
- id: 188
  properties:
    _type: Activity
    activityIsConditional: false
    activityIsConditionalReason: ''
    activityTimelineId: ''
    definedProcedures: []
    description: Adverse events
    id: Activity_31
    label: Activity_31
    name: Adverse events
    nextActivityId: null
    previousActivityId: Activity_30
- id: 189
  properties:
    _type: Content
    contentChildIds:
    - Content_2
    - Content_3
    - Content_7
    - Content_10
    - Content_12
    - Content_21
    - Content_32
    - Content_52
    - Content_60
    - Content_94
    - Content_109
    - Content_115
    - Content_119
    - Content_124
    - Content_132
    - Content_133
    id: Content_1
    label: Content_1
    name: ROOT
    sectionNumber: '0'
    sectionTitle: Root
    text: ''
- id: 190
  properties:
    _type: Content
    contentChildIds: []
    id: Content_2
    label: Content_2
    name: SECTION 0
    sectionNumber: '0'
    sectionTitle: TITLE PAGE
    text: "<table>\n  <tr>\n    <th style=\"vertical-align: top; text-align: left\"\
      ><p>Protocol Full Title:</p></th>\n    <td style=\"vertical-align: top; text-align:\
      \ left\"><p><usdm:ref klass=\"StudyProtocolVersion\" id=\"StudyProtocolVersion_1\"\
      \ attribute=\"officialTitle\"/></p></td>\n  </tr>\n  <tr>\n    <th style=\"\
      vertical-align: top; text-align: left\"><p>Protocol Number:</p></th>\n    <td\
      \ style=\"vertical-align: top; text-align: left\"><p><usdm:ref klass=\"StudyIdentifier\"\
      \ id=\"StudyIdentifier_1\" attribute=\"studyIdentifier\"/></p></td>\n  </tr>\n\
      \  <tr>\n    <th style=\"vertical-align: top; text-align: left\"><p>Version:</p></th>\n\
      \    <td style=\"vertical-align: top; text-align: left\"><p><usdm:ref klass=\"\
      \" namexref=\"\" attribute=\"\"/></p></td>\n  </tr>\n  <tr>\n    <th style=\"\
      vertical-align: top; text-align: left\"><p>Amendment Number:</p></th>\n    <td\
      \ style=\"vertical-align: top; text-align: left\"><p><usdm:ref klass=\"\" namexref=\"\
      \" attribute=\"\"/></p></td>\n  </tr>\n  <tr>\n    <th style=\"vertical-align:\
      \ top; text-align: left\"><p>Amendment Scope:</p></th>\n    <td style=\"vertical-align:\
      \ top; text-align: left\"><p><usdm:ref klass=\"\" namexref=\"\" attribute=\"\
      \"/></p></td>\n  </tr>\n  <tr>\n    <th style=\"vertical-align: top; text-align:\
      \ left\"><p>Compound Number(s):</p></th>\n    <td style=\"vertical-align: top;\
      \ text-align: left\"><p><usdm:ref klass=\"\" namexref=\"\" attribute=\"\"/></p></td>\n\
      \  </tr> \n  <tr>\n    <th style=\"vertical-align: top; text-align: left\"><p>Compound\
      \ Name(s):</p></th>\n    <td style=\"vertical-align: top; text-align: left\"\
      ><p><usdm:ref klass=\"\" namexref=\"\" attribute=\"\"/></p></td>\n  </tr>  \n\
      \  <tr>\n    <th style=\"vertical-align: top; text-align: left\"><p>Trial Phase:</p></th>\n\
      \    <td style=\"vertical-align: top; text-align: left\"><p><usdm:ref klass=\"\
      Code\" id=\"Code_2\" attribute=\"decode\"/></p></td>\n  </tr>\n  <tr>\n    <th\
      \ style=\"vertical-align: top; text-align: left\"><p>Acronym:</p></th>\n   \
      \ <td style=\"vertical-align: top; text-align: left\"><p><usdm:ref klass=\"\
      Study\" namexref=\"STUDY\" attribute=\"studyAcronym\"/></p></td>\n  </tr>\n\
      \  <tr>\n    <th style=\"vertical-align: top; text-align: left\"><p>Short Title:</p></th>\n\
      \    <td style=\"vertical-align: top; text-align: left\"><p><usdm:ref klass=\"\
      StudyProtocolVersion\" id=\"StudyProtocolVersion_1\" attribute=\"briefTitle\"\
      /></p></td>\n  </tr>\n  <tr>\n    <th style=\"vertical-align: top; text-align:\
      \ left\"><p>Sponsor Name and Address:</p></th>\n    <td style=\"vertical-align:\
      \ top; text-align: left\"><p><usdm:ref klass=\"\" namexref=\"\" attribute=\"\
      \"/></p></td>\n  </tr>\n</table>"
- id: 191
  properties:
    _type: Content
    contentChildIds:
    - Content_4
    - Content_5
    - Content_6
    id: Content_3
    label: Content_3
    name: SECTION 1
    sectionNumber: '1'
    sectionTitle: PROTOCOL SUMMARY
    text: ''
- id: 192
  properties:
    _type: Content
    contentChildIds: []
    id: Content_4
    label: Content_4
    name: SECTION 1.1
    sectionNumber: '1.1'
    sectionTitle: Protocol Synopsis
    text: ''
- id: 193
  properties:
    _type: Content
    contentChildIds: []
    id: Content_5
    label: Content_5
    name: SECTION 1.2
    sectionNumber: '1.2'
    sectionTitle: Trial Schema
    text: ''
- id: 194
  properties:
    _type: Content
    contentChildIds: []
    id: Content_6
    label: Content_6
    name: SECTION 1.3
    sectionNumber: '1.3'
    sectionTitle: Schedule of Activities
    text: ''
- id: 195
  properties:
    _type: Content
    contentChildIds:
    - Content_8
    - Content_9
    id: Content_7
    label: Content_7
    name: SECTION 2
    sectionNumber: '2'
    sectionTitle: INTRODUCTION
    text: ''
- id: 196
  properties:
    _type: Content
    contentChildIds: []
    id: Content_8
    label: Content_8
    name: SECTION 2.1
    sectionNumber: '2.1'
    sectionTitle: Purpose of Trial
    text: ''
- id: 197
  properties:
    _type: Content
    contentChildIds: []
    id: Content_9
    label: Content_9
    name: SECTION 2.2
    sectionNumber: '2.2'
    sectionTitle: Summary of Benefits and Risks
    text: ''
- id: 198
  properties:
    _type: Content
    contentChildIds:
    - Content_11
    id: Content_10
    label: Content_10
    name: SECTION 3
    sectionNumber: '3'
    sectionTitle: TRIAL OBJECTIVES, ENDPOINTS AND ESTIMANDS
    text: ''
- id: 199
  properties:
    _type: Content
    contentChildIds: []
    id: Content_11
    label: Content_11
    name: SECTION 3.1
    sectionNumber: '3.1'
    sectionTitle: Primary Objectives
    text: "<table>\n  <tr>\n    <th style=\"vertical-align: top\"><p>Primary Objective</p></th>\n\
      \    <th style=\"vertical-align: top\"><p>Primary Endpoint</p></th>\n  </tr>\n\
      \  <tr>\n    <td style=\"vertical-align: top\"><p><usdm:ref klass=\"Objective\"\
      \ namexref=\"OBJ1\" attribute=\"description\"/></p></td>\n    <td style=\"vertical-align:\
      \ top\">\n      <p><usdm:ref klass=\"Endpoint\" namexref=\"END1\" attribute=\"\
      description\"/></p>\n      <p><usdm:ref klass=\"Endpoint\" namexref=\"END2\"\
      \ attribute=\"description\"/></p>\n    </td>\n  </tr>\n  <tr>\n    <td style=\"\
      vertical-align: top\"><p><usdm:ref klass=\"Objective\" namexref=\"OBJ2\" attribute=\"\
      description\"/></p></td>\n    <td style=\"vertical-align: top\">\n      <p><usdm:ref\
      \ klass=\"Endpoint\" namexref=\"END3\" attribute=\"description\"/></p>\n   \
      \   <p><usdm:ref klass=\"Endpoint\" namexref=\"END4\" attribute=\"description\"\
      /></p>\n      <p><usdm:ref klass=\"Endpoint\" namexref=\"END5\" attribute=\"\
      description\"/></p>\n    </td>\n  </tr>\n</table>"
- id: 200
  properties:
    _type: Content
    contentChildIds:
    - Content_13
    - Content_15
    - Content_19
    - Content_20
    id: Content_12
    label: Content_12
    name: SECTION 4
    sectionNumber: '4'
    sectionTitle: TRIAL DESIGN
    text: ''
- id: 201
  properties:
    _type: Content
    contentChildIds:
    - Content_14
    id: Content_13
    label: Content_13
    name: SECTION 4.1
    sectionNumber: '4.1'
    sectionTitle: Description of Trial Design
    text: ''
- id: 202
  properties:
    _type: Content
    contentChildIds: []
    id: Content_14
    label: Content_14
    name: SECTION 4.1.1
    sectionNumber: 4.1.1
    sectionTitle: Participant Input into Design
    text: ''
- id: 203
  properties:
    _type: Content
    contentChildIds:
    - Content_16
    - Content_17
    - Content_18
    id: Content_15
    label: Content_15
    name: SECTION 4.2
    sectionNumber: '4.2'
    sectionTitle: Rationale for Trial Design
    text: ''
- id: 204
  properties:
    _type: Content
    contentChildIds: []
    id: Content_16
    label: Content_16
    name: SECTION 4.2.1
    sectionNumber: 4.2.1
    sectionTitle: Rationale for Comparator
    text: ''
- id: 205
  properties:
    _type: Content
    contentChildIds: []
    id: Content_17
    label: Content_17
    name: SECTION 4.2.2
    sectionNumber: 4.2.2
    sectionTitle: Rationale for Adaptive or Novel Trial Design
    text: ''
- id: 206
  properties:
    _type: Content
    contentChildIds: []
    id: Content_18
    label: Content_18
    name: SECTION 4.2.3
    sectionNumber: 4.2.3
    sectionTitle: Other Trial Design Considerations
    text: ''
- id: 207
  properties:
    _type: Content
    contentChildIds: []
    id: Content_19
    label: Content_19
    name: SECTION 4.3
    sectionNumber: '4.3'
    sectionTitle: Access to Trial Intervention After End of Trial
    text: ''
- id: 208
  properties:
    _type: Content
    contentChildIds: []
    id: Content_20
    label: Content_20
    name: SECTION 4.4
    sectionNumber: '4.4'
    sectionTitle: Start of Trial and End of Trial
    text: ''
- id: 209
  properties:
    _type: Content
    contentChildIds:
    - Content_22
    - Content_23
    - Content_24
    - Content_25
    - Content_26
    - Content_31
    id: Content_21
    label: Content_21
    name: SECTION 5
    sectionNumber: '5'
    sectionTitle: TRIAL POPULATION
    text: ''
- id: 210
  properties:
    _type: Content
    contentChildIds: []
    id: Content_22
    label: Content_22
    name: SECTION 5.1
    sectionNumber: '5.1'
    sectionTitle: Selection of Trial Population
    text: ''
- id: 211
  properties:
    _type: Content
    contentChildIds: []
    id: Content_23
    label: Content_23
    name: SECTION 5.2
    sectionNumber: '5.2'
    sectionTitle: Rationale for Trial Population
    text: ''
- id: 212
  properties:
    _type: Content
    contentChildIds: []
    id: Content_24
    label: Content_24
    name: SECTION 5.3
    sectionNumber: '5.3'
    sectionTitle: Inclusion Criteria
    text: "<p>Patients may be included in the study only if they meet <strong>all</strong>\
      \ the following criteria:</p>\n<table>\n  <tr>\n    <td style=\"vertical-align:\
      \ top\">[1]</td>\n    <td style=\"vertical-align: top\">\n      Males and postmenopausal\
      \ females at least 50 years of age.\n    </td>\n  </tr>\n  <tr>\n    <td style=\"\
      vertical-align: top\">[2]</td>\n    <td style=\"vertical-align: top\">Diagnosis\
      \ of probable AD as defined by National Institute of Neurological and Communicative\
      \ Disorders and Stroke\n      (NINCDS) and the Alzheimer\u2019s Disease and\
      \ Related Disorders Association (ADRDA) guidelines (Attachment LZZT.7).\n  </tr>\n\
      \  <tr>\n    <td style=\"vertical-align: top\">[3]</td>\n    <td style=\"vertical-align:\
      \ top\">MMSE score of 10 to 23.</td> \n  </tr>\n  <tr>\n    <td style=\"vertical-align:\
      \ top\">[4]</td>\n    <td style=\"vertical-align: top\">Hachinski Ischemic Scale\
      \ score of \u22644 (Attachment LZZT.8).</td>\n  </tr>\n  <tr>\n    <td style=\"\
      vertical-align: top\">[5]</td>\n    <td style=\"vertical-align: top\">CNS imaging\
      \ (CT scan or MRI of brain) compatible with AD within past 1 year.\n      The\
      \ following findings are incompatible with AD:\n      <ol type=\"a\">\n    \
      \    <li>Large vessel strokes\n          <ol type=\"1\">\n            <li>Any\
      \ definite area of encephalomalacia consistent with ischemic necrosis in any\
      \ cerebral artery\n              territory.</li>\n            <li>Large, confluent\
      \ areas of encephalomalacia in parieto-occipital or frontal regions consistent\
      \ with\n              watershed infarcts. The above are exclusionary. Exceptions\
      \ are made for small areas of cortical asymmetry\n              which may represent\
      \ a small cortical stroke or a focal area of atrophy provided there is no abnormal\n\
      \              signal intensity in the immediately underlying parenchyma. Only\
      \ one such questionable area allowed per\n              scan, and size is restricted\
      \ to \u22641cm in frontal/parietal/temporal cortices and \u22642 cm in occipital\
      \ cortex.\n            </li>\n          </ol>\n        </li>\n        <li>Small\
      \ vessel ischemia\n          <ol type=\"1\">\n            <li>Lacunar infarct\
      \ is defined as an area of abnormal intensity seen on CT scan or on both T1\
      \ and T2\n              weighted MRI images in the basal ganglia, thalamus or\
      \ deep white matter which is \u22641 cm in maximal\n              diameter.\
      \ A maximum of one lacune is allowed per scan.</li>\n            <li>Leukoariosis\
      \ or leukoencephalopathy is regarded as an abnormality seen on T2 but not T1\
      \ weighted MRIs,\n              or on CT. This is accepted if mild or moderate\
      \ in extent, meaning involvement of less than 25% of cortical\n            \
      \  white matter.</li>\n          </ol>\n        </li>\n        <li>Miscellaneous\n\
      \          <ol type=\"1\">\n            <li>Benign small extra-axial tumors\
      \ (ie, meningiomas) are accepted if they do not contact or indent the\n    \
      \          brain parenchyma.</li>\n            <li>extra-axial arachnoid cysts\
      \ are accepted if they do not indent or deform the brain parenchyma.</li>\n\
      \          </ol>\n        </li>\n      </ol>\n    </td>\n  </tr>\n  <tr>\n \
      \   <td style=\"vertical-align: top\">[6]</td>\n    <td style=\"vertical-align:\
      \ top\">Investigator has obtained informed consent signed by the patient (and/or\
      \ legal representative) and by the\n      caregiver.</td>\n  </tr>\n  <tr>\n\
      \    <td style=\"vertical-align: top\">[7]</td>\n    <td style=\"vertical-align:\
      \ top\">Geographic proximity to investigator\u2019s site that allows adequate\
      \ follow-up.</td>\n  </tr>\n  <tr>\n    <td style=\"vertical-align: top\">[8]</td>\n\
      \    <td style=\"vertical-align: top\">A reliable caregiver who is in frequent\
      \ or daily contact with the patient and who will accompany the patient to\n\
      \      the office and/or be available by telephone at designated times, will\
      \ monitor administration of prescribed\n      medications, and will be responsible\
      \ for the overall care of the patient at home. The caregiver and the patient\n\
      \      must be able to communicate in English and willing to comply with 26\
      \ weeks of transdermal therapy.</td>\n  </tr>\n<table>"
- id: 213
  properties:
    _type: Content
    contentChildIds: []
    id: Content_25
    label: Content_25
    name: SECTION 5.4
    sectionNumber: '5.4'
    sectionTitle: Exclusion Criteria
    text: ''
- id: 214
  properties:
    _type: Content
    contentChildIds:
    - Content_27
    - Content_28
    - Content_29
    - Content_30
    id: Content_26
    label: Content_26
    name: SECTION 5.5
    sectionNumber: '5.5'
    sectionTitle: Lifestyle Considerations
    text: ''
- id: 215
  properties:
    _type: Content
    contentChildIds: []
    id: Content_27
    label: Content_27
    name: SECTION 5.5.1
    sectionNumber: 5.5.1
    sectionTitle: Meals and Dietary Restrictions
    text: ''
- id: 216
  properties:
    _type: Content
    contentChildIds: []
    id: Content_28
    label: Content_28
    name: SECTION 5.5.2
    sectionNumber: 5.5.2
    sectionTitle: Caffeine, Alcohol, Tobacco, and Other Habits
    text: ''
- id: 217
  properties:
    _type: Content
    contentChildIds: []
    id: Content_29
    label: Content_29
    name: SECTION 5.5.3
    sectionNumber: 5.5.3
    sectionTitle: Physical Activity
    text: ''
- id: 218
  properties:
    _type: Content
    contentChildIds: []
    id: Content_30
    label: Content_30
    name: SECTION 5.5.4
    sectionNumber: 5.5.4
    sectionTitle: Other Activity
    text: ''
- id: 219
  properties:
    _type: Content
    contentChildIds: []
    id: Content_31
    label: Content_31
    name: SECTION 5.6
    sectionNumber: '5.6'
    sectionTitle: Screen Failures
    text: ''
- id: 220
  properties:
    _type: Content
    contentChildIds:
    - Content_33
    - Content_34
    - Content_35
    - Content_37
    - Content_38
    - Content_42
    - Content_46
    - Content_47
    id: Content_32
    label: Content_32
    name: SECTION 6
    sectionNumber: '6'
    sectionTitle: TRIAL INTERVENTION AND CONCOMITANT THERAPY
    text: ''
- id: 221
  properties:
    _type: Content
    contentChildIds: []
    id: Content_33
    label: Content_33
    name: SECTION 6.1
    sectionNumber: '6.1'
    sectionTitle: Description of Trial Intervention
    text: ''
- id: 222
  properties:
    _type: Content
    contentChildIds: []
    id: Content_34
    label: Content_34
    name: SECTION 6.2
    sectionNumber: '6.2'
    sectionTitle: Rationale for Trial Intervention
    text: ''
- id: 223
  properties:
    _type: Content
    contentChildIds:
    - Content_36
    id: Content_35
    label: Content_35
    name: SECTION 6.3
    sectionNumber: '6.3'
    sectionTitle: Dosing and Administration
    text: ''
- id: 224
  properties:
    _type: Content
    contentChildIds: []
    id: Content_36
    label: Content_36
    name: SECTION 6.3.1
    sectionNumber: 6.3.1
    sectionTitle: Trial Intervention Dose Modification
    text: ''
- id: 225
  properties:
    _type: Content
    contentChildIds: []
    id: Content_37
    label: Content_37
    name: SECTION 6.4
    sectionNumber: '6.4'
    sectionTitle: Treatment of Overdose
    text: ''
- id: 226
  properties:
    _type: Content
    contentChildIds:
    - Content_39
    - Content_40
    - Content_41
    id: Content_38
    label: Content_38
    name: SECTION 6.5
    sectionNumber: '6.5'
    sectionTitle: Preparation, Handling, Storage and Accountability
    text: ''
- id: 227
  properties:
    _type: Content
    contentChildIds: []
    id: Content_39
    label: Content_39
    name: SECTION 6.5.1
    sectionNumber: 6.5.1
    sectionTitle: Preparation of Trial Intervention
    text: ''
- id: 228
  properties:
    _type: Content
    contentChildIds: []
    id: Content_40
    label: Content_40
    name: SECTION 6.5.2
    sectionNumber: 6.5.2
    sectionTitle: Handling and Storage of Trial Intervention
    text: ''
- id: 229
  properties:
    _type: Content
    contentChildIds: []
    id: Content_41
    label: Content_41
    name: SECTION 6.5.3
    sectionNumber: 6.5.3
    sectionTitle: Accountability of Trial Intervention
    text: ''
- id: 230
  properties:
    _type: Content
    contentChildIds:
    - Content_43
    - Content_44
    - Content_45
    id: Content_42
    label: Content_42
    name: SECTION 6.6
    sectionNumber: '6.6'
    sectionTitle: Participant Assignment, Randomisation and Blinding
    text: ''
- id: 231
  properties:
    _type: Content
    contentChildIds: []
    id: Content_43
    label: Content_43
    name: SECTION 6.6.1
    sectionNumber: 6.6.1
    sectionTitle: Participant Assignment
    text: ''
- id: 232
  properties:
    _type: Content
    contentChildIds: []
    id: Content_44
    label: Content_44
    name: SECTION 6.6.2
    sectionNumber: 6.6.2
    sectionTitle: Randomisation
    text: ''
- id: 233
  properties:
    _type: Content
    contentChildIds: []
    id: Content_45
    label: Content_45
    name: SECTION 6.6.3
    sectionNumber: 6.6.3
    sectionTitle: Blinding and Unblinding
    text: "<p>The study will be double-blind. To further preserve the blinding of\
      \ the study, only a minimum number of Lilly and CRO personnel will see the randomization\
      \ table and codes before the study is complete.</p>\n<p>Emergency codes generated\
      \ by a computer drug-labeling system will be available to the investigator.\
      \ These codes, which reveal the patients treatment group, may be opened during\
      \ the study only if the choice of follow-up treatment depends on the patient\u2019\
      s therapy assignment.</p>\n<p>The investigator should make every effort to contact\
      \ the clinical research physician prior to unblinding a patient\u2019s therapy\
      \ assignment. If a patient\u2019s therapy assignment is unblinded, Lilly must\
      \ be notified immediately by telephone. After the study, the investigator must\
      \ return all sealed and any opened codes.</p>"
- id: 234
  properties:
    _type: Content
    contentChildIds: []
    id: Content_46
    label: Content_46
    name: SECTION 6.7
    sectionNumber: '6.7'
    sectionTitle: Trial Intervention Compliance
    text: ''
- id: 235
  properties:
    _type: Content
    contentChildIds:
    - Content_48
    - Content_49
    - Content_50
    - Content_51
    id: Content_47
    label: Content_47
    name: SECTION 6.8
    sectionNumber: '6.8'
    sectionTitle: Concomitant Therapy
    text: ''
- id: 236
  properties:
    _type: Content
    contentChildIds: []
    id: Content_48
    label: Content_48
    name: SECTION 6.8.1
    sectionNumber: 6.8.1
    sectionTitle: Prohibited Concomitant Therapy
    text: ''
- id: 237
  properties:
    _type: Content
    contentChildIds: []
    id: Content_49
    label: Content_49
    name: SECTION 6.8.2
    sectionNumber: 6.8.2
    sectionTitle: Permitted Concomitant Therapy
    text: ''
- id: 238
  properties:
    _type: Content
    contentChildIds: []
    id: Content_50
    label: Content_50
    name: SECTION 6.8.3
    sectionNumber: 6.8.3
    sectionTitle: Rescue Therapy
    text: ''
- id: 239
  properties:
    _type: Content
    contentChildIds: []
    id: Content_51
    label: Content_51
    name: SECTION 6.8.4
    sectionNumber: 6.8.4
    sectionTitle: Other Therapy
    text: ''
- id: 240
  properties:
    _type: Content
    contentChildIds:
    - Content_53
    - Content_57
    - Content_58
    - Content_59
    id: Content_52
    label: Content_52
    name: SECTION 7
    sectionNumber: '7'
    sectionTitle: DISCONTINUATION OF TRIAL INTERVENTION AND PARTICIPANT WITHDRAWAL
      FROM TRIAL
    text: ''
- id: 241
  properties:
    _type: Content
    contentChildIds:
    - Content_54
    - Content_55
    - Content_56
    id: Content_53
    label: Content_53
    name: SECTION 7.1
    sectionNumber: '7.1'
    sectionTitle: Discontinuation of Trial Intervention
    text: ''
- id: 242
  properties:
    _type: Content
    contentChildIds: []
    id: Content_54
    label: Content_54
    name: SECTION 7.1.1
    sectionNumber: 7.1.1
    sectionTitle: Criteria for Permanent Discontinuation of Trial Intervention
    text: ''
- id: 243
  properties:
    _type: Content
    contentChildIds: []
    id: Content_55
    label: Content_55
    name: SECTION 7.1.2
    sectionNumber: 7.1.2
    sectionTitle: Temporary Discontinuation or Interruption of Trial Intervention
    text: ''
- id: 244
  properties:
    _type: Content
    contentChildIds: []
    id: Content_56
    label: Content_56
    name: SECTION 7.1.3
    sectionNumber: 7.1.3
    sectionTitle: Rechallenge
    text: ''
- id: 245
  properties:
    _type: Content
    contentChildIds: []
    id: Content_57
    label: Content_57
    name: SECTION 7.2
    sectionNumber: '7.2'
    sectionTitle: Participant Withdrawal from the Trial
    text: ''
- id: 246
  properties:
    _type: Content
    contentChildIds: []
    id: Content_58
    label: Content_58
    name: SECTION 7.3
    sectionNumber: '7.3'
    sectionTitle: Lost to Follow-Up
    text: ''
- id: 247
  properties:
    _type: Content
    contentChildIds: []
    id: Content_59
    label: Content_59
    name: SECTION 7.4
    sectionNumber: '7.4'
    sectionTitle: Trial Stopping Rules
    text: ''
- id: 248
  properties:
    _type: Content
    contentChildIds:
    - Content_61
    - Content_62
    - Content_63
    - Content_69
    - Content_80
    - Content_83
    - Content_89
    - Content_90
    - Content_91
    - Content_92
    id: Content_60
    label: Content_60
    name: SECTION 8
    sectionNumber: '8'
    sectionTitle: TRIAL ASSESSMENTS AND PROCEDURES
    text: ''
- id: 249
  properties:
    _type: Content
    contentChildIds: []
    id: Content_61
    label: Content_61
    name: SECTION 8.1
    sectionNumber: '8.1'
    sectionTitle: Screening/Baseline Assessments and Procedures
    text: ''
- id: 250
  properties:
    _type: Content
    contentChildIds: []
    id: Content_62
    label: Content_62
    name: SECTION 8.2
    sectionNumber: '8.2'
    sectionTitle: Efficacy Assessments and Procedures
    text: ''
- id: 251
  properties:
    _type: Content
    contentChildIds:
    - Content_64
    - Content_65
    - Content_66
    - Content_67
    - Content_68
    id: Content_63
    label: Content_63
    name: SECTION 8.3
    sectionNumber: '8.3'
    sectionTitle: Safety Assessments and Procedures
    text: ''
- id: 252
  properties:
    _type: Content
    contentChildIds: []
    id: Content_64
    label: Content_64
    name: SECTION 8.3.1
    sectionNumber: 8.3.1
    sectionTitle: Physical Examination
    text: ''
- id: 253
  properties:
    _type: Content
    contentChildIds: []
    id: Content_65
    label: Content_65
    name: SECTION 8.3.2
    sectionNumber: 8.3.2
    sectionTitle: Vital Signs
    text: ''
- id: 254
  properties:
    _type: Content
    contentChildIds: []
    id: Content_66
    label: Content_66
    name: SECTION 8.3.3
    sectionNumber: 8.3.3
    sectionTitle: Electrocardiograms
    text: ''
- id: 255
  properties:
    _type: Content
    contentChildIds: []
    id: Content_67
    label: Content_67
    name: SECTION 8.3.4
    sectionNumber: 8.3.4
    sectionTitle: Clinical Laboratory Assessments
    text: ''
- id: 256
  properties:
    _type: Content
    contentChildIds: []
    id: Content_68
    label: Content_68
    name: SECTION 8.3.5
    sectionNumber: 8.3.5
    sectionTitle: Suicidal Ideation and Behaviour Risk Monitoring
    text: ''
- id: 257
  properties:
    _type: Content
    contentChildIds:
    - Content_70
    - Content_71
    - Content_72
    - Content_73
    - Content_74
    - Content_75
    - Content_76
    - Content_77
    - Content_78
    - Content_79
    id: Content_69
    label: Content_69
    name: SECTION 8.4
    sectionNumber: '8.4'
    sectionTitle: Adverse Events and Serious Adverse Events
    text: ''
- id: 258
  properties:
    _type: Content
    contentChildIds: []
    id: Content_70
    label: Content_70
    name: SECTION 8.4.1
    sectionNumber: 8.4.1
    sectionTitle: Definitions of AE and SAE
    text: ''
- id: 259
  properties:
    _type: Content
    contentChildIds: []
    id: Content_71
    label: Content_71
    name: SECTION 8.4.2
    sectionNumber: 8.4.2
    sectionTitle: Time Period and Frequency for Collecting AE and SAE Information
    text: ''
- id: 260
  properties:
    _type: Content
    contentChildIds: []
    id: Content_72
    label: Content_72
    name: SECTION 8.4.3
    sectionNumber: 8.4.3
    sectionTitle: Identifying AEs and SAEs
    text: ''
- id: 261
  properties:
    _type: Content
    contentChildIds: []
    id: Content_73
    label: Content_73
    name: SECTION 8.4.4
    sectionNumber: 8.4.4
    sectionTitle: Recording of AEs and SAEs
    text: ''
- id: 262
  properties:
    _type: Content
    contentChildIds: []
    id: Content_74
    label: Content_74
    name: SECTION 8.4.5
    sectionNumber: 8.4.5
    sectionTitle: Follow-up of AEs and SAEs
    text: ''
- id: 263
  properties:
    _type: Content
    contentChildIds: []
    id: Content_75
    label: Content_75
    name: SECTION 8.4.6
    sectionNumber: 8.4.6
    sectionTitle: Reporting of SAEs
    text: ''
- id: 264
  properties:
    _type: Content
    contentChildIds: []
    id: Content_76
    label: Content_76
    name: SECTION 8.4.7
    sectionNumber: 8.4.7
    sectionTitle: Regulatory Reporting Requirements for SAEs
    text: ''
- id: 265
  properties:
    _type: Content
    contentChildIds: []
    id: Content_77
    label: Content_77
    name: SECTION 8.4.8
    sectionNumber: 8.4.8
    sectionTitle: Serious and Unexpected Adverse Reaction Reporting
    text: ''
- id: 266
  properties:
    _type: Content
    contentChildIds: []
    id: Content_78
    label: Content_78
    name: SECTION 8.4.9
    sectionNumber: 8.4.9
    sectionTitle: Adverse Events of Special Interest
    text: ''
- id: 267
  properties:
    _type: Content
    contentChildIds: []
    id: Content_79
    label: Content_79
    name: SECTION 8.4.10
    sectionNumber: 8.4.10
    sectionTitle: Disease-related Events or Outcomes Not Qualifying as AEs or SAEs
    text: ''
- id: 268
  properties:
    _type: Content
    contentChildIds:
    - Content_81
    - Content_82
    id: Content_80
    label: Content_80
    name: SECTION 8.5
    sectionNumber: '8.5'
    sectionTitle: Pregnancy and Postpartum Information
    text: ''
- id: 269
  properties:
    _type: Content
    contentChildIds: []
    id: Content_81
    label: Content_81
    name: SECTION 8.5.1
    sectionNumber: 8.5.1
    sectionTitle: Participants Who Become Pregnant During the Trial
    text: ''
- id: 270
  properties:
    _type: Content
    contentChildIds: []
    id: Content_82
    label: Content_82
    name: SECTION 8.5.2
    sectionNumber: 8.5.2
    sectionTitle: Participants Whose Partners Become Pregnant
    text: ''
- id: 271
  properties:
    _type: Content
    contentChildIds:
    - Content_84
    - Content_85
    - Content_86
    - Content_87
    - Content_88
    id: Content_83
    label: Content_83
    name: SECTION 8.6
    sectionNumber: '8.6'
    sectionTitle: Medical Device Product Complaints for Drug/Device Combination Products
    text: ''
- id: 272
  properties:
    _type: Content
    contentChildIds: []
    id: Content_84
    label: Content_84
    name: SECTION 8.6.1
    sectionNumber: 8.6.1
    sectionTitle: Definition of Medical Device Product Complaints
    text: ''
- id: 273
  properties:
    _type: Content
    contentChildIds: []
    id: Content_85
    label: Content_85
    name: SECTION 8.6.2
    sectionNumber: 8.6.2
    sectionTitle: Recording of Medical Device Product Complaints
    text: ''
- id: 274
  properties:
    _type: Content
    contentChildIds: []
    id: Content_86
    label: Content_86
    name: SECTION 8.6.3
    sectionNumber: 8.6.3
    sectionTitle: Time Period and Frequency for Collecting Medical Device Product
      Complaints .
    text: ''
- id: 275
  properties:
    _type: Content
    contentChildIds: []
    id: Content_87
    label: Content_87
    name: SECTION 8.6.4
    sectionNumber: 8.6.4
    sectionTitle: Follow-Up of Medical Device Product Complaints
    text: ''
- id: 276
  properties:
    _type: Content
    contentChildIds: []
    id: Content_88
    label: Content_88
    name: SECTION 8.6.5
    sectionNumber: 8.6.5
    sectionTitle: Regulatory Reporting Requirements for Medical Device Product Complaints
    text: ''
- id: 277
  properties:
    _type: Content
    contentChildIds: []
    id: Content_89
    label: Content_89
    name: SECTION 8.7
    sectionNumber: '8.7'
    sectionTitle: Pharmacokinetics
    text: ''
- id: 278
  properties:
    _type: Content
    contentChildIds: []
    id: Content_90
    label: Content_90
    name: SECTION 8.8
    sectionNumber: '8.8'
    sectionTitle: Genetics
    text: ''
- id: 279
  properties:
    _type: Content
    contentChildIds: []
    id: Content_91
    label: Content_91
    name: SECTION 8.9
    sectionNumber: '8.9'
    sectionTitle: Biomarkers
    text: ''
- id: 280
  properties:
    _type: Content
    contentChildIds:
    - Content_93
    id: Content_92
    label: Content_92
    name: SECTION 8.1
    sectionNumber: '8.1'
    sectionTitle: Immunogenicity Assessments
    text: ''
- id: 281
  properties:
    _type: Content
    contentChildIds: []
    id: Content_93
    label: Content_93
    name: SECTION 8.1.1
    sectionNumber: 8.1.1
    sectionTitle: Medical Resource Utilisation and Health Economics
    text: ''
- id: 282
  properties:
    _type: Content
    contentChildIds:
    - Content_95
    - Content_96
    - Content_102
    - Content_103
    - Content_104
    - Content_105
    - Content_106
    - Content_107
    - Content_108
    id: Content_94
    label: Content_94
    name: SECTION 9
    sectionNumber: '9'
    sectionTitle: STATISTICAL CONSIDERATIONS
    text: ''
- id: 283
  properties:
    _type: Content
    contentChildIds: []
    id: Content_95
    label: Content_95
    name: SECTION 9.1
    sectionNumber: '9.1'
    sectionTitle: Analysis Sets
    text: ''
- id: 284
  properties:
    _type: Content
    contentChildIds:
    - Content_97
    - Content_98
    - Content_99
    - Content_100
    - Content_101
    id: Content_96
    label: Content_96
    name: SECTION 9.2
    sectionNumber: '9.2'
    sectionTitle: Analyses Supporting Primary Objective(s)
    text: ''
- id: 285
  properties:
    _type: Content
    contentChildIds: []
    id: Content_97
    label: Content_97
    name: SECTION 9.2.1
    sectionNumber: 9.2.1
    sectionTitle: Statistical Model, Hypothesis, and Method of Analysis
    text: ''
- id: 286
  properties:
    _type: Content
    contentChildIds: []
    id: Content_98
    label: Content_98
    name: SECTION 9.2.2
    sectionNumber: 9.2.2
    sectionTitle: Handling of Intercurrent Events of Primary Estimand(s)
    text: ''
- id: 287
  properties:
    _type: Content
    contentChildIds: []
    id: Content_99
    label: Content_99
    name: SECTION 9.2.3
    sectionNumber: 9.2.3
    sectionTitle: Handling of Missing Data
    text: ''
- id: 288
  properties:
    _type: Content
    contentChildIds: []
    id: Content_100
    label: Content_100
    name: SECTION 9.2.4
    sectionNumber: 9.2.4
    sectionTitle: Sensitivity Analysis
    text: ''
- id: 289
  properties:
    _type: Content
    contentChildIds: []
    id: Content_101
    label: Content_101
    name: SECTION 9.2.5
    sectionNumber: 9.2.5
    sectionTitle: Supplementary Analysis
    text: ''
- id: 290
  properties:
    _type: Content
    contentChildIds: []
    id: Content_102
    label: Content_102
    name: SECTION 9.3
    sectionNumber: '9.3'
    sectionTitle: Analysis Supporting Secondary Objective(s)
    text: ''
- id: 291
  properties:
    _type: Content
    contentChildIds: []
    id: Content_103
    label: Content_103
    name: SECTION 9.4
    sectionNumber: '9.4'
    sectionTitle: Analysis of Exploratory Objective(s)
    text: ''
- id: 292
  properties:
    _type: Content
    contentChildIds: []
    id: Content_104
    label: Content_104
    name: SECTION 9.5
    sectionNumber: '9.5'
    sectionTitle: Safety Analyses
    text: ''
- id: 293
  properties:
    _type: Content
    contentChildIds: []
    id: Content_105
    label: Content_105
    name: SECTION 9.6
    sectionNumber: '9.6'
    sectionTitle: Other Analyses
    text: ''
- id: 294
  properties:
    _type: Content
    contentChildIds: []
    id: Content_106
    label: Content_106
    name: SECTION 9.7
    sectionNumber: '9.7'
    sectionTitle: Interim Analyses
    text: ''
- id: 295
  properties:
    _type: Content
    contentChildIds: []
    id: Content_107
    label: Content_107
    name: SECTION 9.8
    sectionNumber: '9.8'
    sectionTitle: Sample Size Determination
    text: ''
- id: 296
  properties:
    _type: Content
    contentChildIds: []
    id: Content_108
    label: Content_108
    name: SECTION 9.9
    sectionNumber: '9.9'
    sectionTitle: Protocol Deviations
    text: ''
- id: 297
  properties:
    _type: Content
    contentChildIds:
    - Content_110
    - Content_111
    - Content_112
    - Content_113
    - Content_114
    id: Content_109
    label: Content_109
    name: SECTION 10
    sectionNumber: '10'
    sectionTitle: 'GENERAL CONSIDERATIONS: REGULATORY, ETHICAL, AND TRIAL OVERSIGHT'
    text: ''
- id: 298
  properties:
    _type: Content
    contentChildIds: []
    id: Content_110
    label: Content_110
    name: SECTION 10.1
    sectionNumber: '10.1'
    sectionTitle: Regulatory and Ethical Considerations
    text: ''
- id: 299
  properties:
    _type: Content
    contentChildIds: []
    id: Content_111
    label: Content_111
    name: SECTION 10.2
    sectionNumber: '10.2'
    sectionTitle: Committees
    text: ''
- id: 300
  properties:
    _type: Content
    contentChildIds: []
    id: Content_112
    label: Content_112
    name: SECTION 10.3
    sectionNumber: '10.3'
    sectionTitle: Informed Consent Process
    text: ''
- id: 301
  properties:
    _type: Content
    contentChildIds: []
    id: Content_113
    label: Content_113
    name: SECTION 10.4
    sectionNumber: '10.4'
    sectionTitle: Data Protection
    text: ''
- id: 302
  properties:
    _type: Content
    contentChildIds: []
    id: Content_114
    label: Content_114
    name: SECTION 10.5
    sectionNumber: '10.5'
    sectionTitle: Early Site Closure or Trial Termination
    text: ''
- id: 303
  properties:
    _type: Content
    contentChildIds:
    - Content_116
    - Content_117
    - Content_118
    id: Content_115
    label: Content_115
    name: SECTION 11
    sectionNumber: '11'
    sectionTitle: 'GENERAL CONSIDERATIONS: RISK MANAGEMENT AND QUALITY ASSURANCE'
    text: ''
- id: 304
  properties:
    _type: Content
    contentChildIds: []
    id: Content_116
    label: Content_116
    name: SECTION 11.1
    sectionNumber: '11.1'
    sectionTitle: Quality Tolerance Limits
    text: ''
- id: 305
  properties:
    _type: Content
    contentChildIds: []
    id: Content_117
    label: Content_117
    name: SECTION 11.2
    sectionNumber: '11.2'
    sectionTitle: Data Quality Assurance
    text: ''
- id: 306
  properties:
    _type: Content
    contentChildIds: []
    id: Content_118
    label: Content_118
    name: SECTION 11.3
    sectionNumber: '11.3'
    sectionTitle: Source Data
    text: ''
- id: 307
  properties:
    _type: Content
    contentChildIds:
    - Content_120
    - Content_121
    - Content_122
    - Content_123
    id: Content_119
    label: Content_119
    name: SECTION 12
    sectionNumber: '12'
    sectionTitle: 'APPENDIX: ADVERSE EVENTS AND SERIOUS ADVERSE EVENTS - DEFINITIONS,
      SEVERITY, AND CAUSALITY'
    text: ''
- id: 308
  properties:
    _type: Content
    contentChildIds: []
    id: Content_120
    label: Content_120
    name: SECTION 12.1
    sectionNumber: '12.1'
    sectionTitle: Further Details and Clarifications on the AE Definition
    text: ''
- id: 309
  properties:
    _type: Content
    contentChildIds: []
    id: Content_121
    label: Content_121
    name: SECTION 12.2
    sectionNumber: '12.2'
    sectionTitle: Further Details and Clarifications on the SAE Definition
    text: ''
- id: 310
  properties:
    _type: Content
    contentChildIds: []
    id: Content_122
    label: Content_122
    name: SECTION 12.3
    sectionNumber: '12.3'
    sectionTitle: Severity
    text: ''
- id: 311
  properties:
    _type: Content
    contentChildIds: []
    id: Content_123
    label: Content_123
    name: SECTION 12.4
    sectionNumber: '12.4'
    sectionTitle: Causality
    text: ''
- id: 312
  properties:
    _type: Content
    contentChildIds:
    - Content_125
    - Content_129
    - Content_130
    - Content_131
    id: Content_124
    label: Content_124
    name: SECTION 13
    sectionNumber: '13'
    sectionTitle: 'APPENDIX: DEFINITIONS AND SUPPORTING OPERATIONAL DETAILS'
    text: ''
- id: 313
  properties:
    _type: Content
    contentChildIds:
    - Content_126
    - Content_127
    - Content_128
    id: Content_125
    label: Content_125
    name: SECTION 13.1
    sectionNumber: '13.1'
    sectionTitle: Contraception and Pregnancy Testing
    text: ''
- id: 314
  properties:
    _type: Content
    contentChildIds: []
    id: Content_126
    label: Content_126
    name: SECTION 13.1.1
    sectionNumber: 13.1.1
    sectionTitle: Definitions Related to Childbearing Potential
    text: ''
- id: 315
  properties:
    _type: Content
    contentChildIds: []
    id: Content_127
    label: Content_127
    name: SECTION 13.1.2
    sectionNumber: 13.1.2
    sectionTitle: Contraception
    text: ''
- id: 316
  properties:
    _type: Content
    contentChildIds: []
    id: Content_128
    label: Content_128
    name: SECTION 13.1.3
    sectionNumber: 13.1.3
    sectionTitle: Pregnancy Testing
    text: ''
- id: 317
  properties:
    _type: Content
    contentChildIds: []
    id: Content_129
    label: Content_129
    name: SECTION 13.2
    sectionNumber: '13.2'
    sectionTitle: Clinical Laboratory Tests
    text: ''
- id: 318
  properties:
    _type: Content
    contentChildIds: []
    id: Content_130
    label: Content_130
    name: SECTION 13.3
    sectionNumber: '13.3'
    sectionTitle: Country/Region-Specific Differences
    text: ''
- id: 319
  properties:
    _type: Content
    contentChildIds: []
    id: Content_131
    label: Content_131
    name: SECTION 13.4
    sectionNumber: '13.4'
    sectionTitle: Prior Protocol Amendments
    text: ''
- id: 320
  properties:
    _type: Content
    contentChildIds: []
    id: Content_132
    label: Content_132
    name: SECTION 14
    sectionNumber: '14'
    sectionTitle: 'APPENDIX: GLOSSARY OF TERMS'
    text: ''
- id: 321
  properties:
    _type: Content
    contentChildIds: []
    id: Content_133
    label: Content_133
    name: SECTION 15
    sectionNumber: '15'
    sectionTitle: 'APPENDIX: REFERENCES'
    text: ''
- id: 4
  properties:
    _type: StudyDesign
    bcCategories: []
    bcSurrogates: {}
    biomedicalConcepts: {}
    description: The main design for the study
    id: StudyDesign_1
    interventionModel:
      _type: Code
      code: C82639
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Parallel Study
      id: Code_79
    label: StudyDesign_1
    name: Study Design 1
    studyArms: {}
    studyCells: {}
    studyDesignBlindingScheme: {}
    studyDesignRationale: The discontinuation rate associated with this oral dosing
      regimen was 58.6% in previous studies, and alternative clinical strategies have
      been sought to improve tolerance for the compound. To that end, development
      of a Transdermal Therapeutic System (TTS) has been initiated.
    studyElements: {}
    studyEpochs: {}
    studyEstimands: []
    studyIndications: {}
    studyInvestigationalInterventions: []
    studyObjectives: {}
    studyPopulations: {}
    therapeuticAreas:
    - _type: Code
      code: MILD_MOD_ALZ
      codeSystem: SPONSOR
      codeSystemVersion: '12'
      decode: Mild to Moderate Alzheimer\'s Disease
      id: Code_72
    - _type: Code
      code: '26929004'
      codeSystem: SNOMED
      codeSystemVersion: January 31, 2018
      decode: Alzheimer\'s disease
      id: Code_73
    trialIntentTypes:
    - _type: Code
      code: C49656
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Treatment Study
      id: Code_75
    trialTypes:
    - _type: Code
      code: C49666
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Efficacy Study
      id: Code_76
    - _type: Code
      code: C49667
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Safety Study
      id: Code_77
    - _type: Code
      code: C49663
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Pharmacokinetic Study
      id: Code_78
- id: 1
  properties:
    _type: Study
    businessTherapeuticAreas:
    - _type: Code
      code: PHARMA
      codeSystem: SPONSOR
      codeSystemVersion: '12'
      decode: Eli Lilly
      id: Code_3
    id: null
    label: Study
    studyAcronym: H2Q-MC-LZZT
    studyIdentifiers: {}
    studyPhase: {}
    studyProtocolVersions: {}
    studyRationale: The discontinuation rate associated with this oral dosing regimen
      was 58.6% in previous studies, and alternative clinical strategies have been
      sought to improve tolerance for the compound. To that end, development of a
      Transdermal Therapeutic System (TTS) has been initiated.
    studyTitle: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System
      (TTS) in Patients with Mild to Moderate Alzheimer's Disease
    studyVersion: '1'
    type:
      _type: Code
      code: C98388
      codeSystem: http://www.cdisc.org
      codeSystemVersion: '2022-12-16'
      decode: Interventional Study
      id: Code_1
